William Blair Comments on Neogen Co.’s Q1 2025 Earnings (NASDAQ:NEOG)

Neogen Co. (NASDAQ:NEOG) – Investment analysts at William Blair cut their Q1 2025 EPS estimates for Neogen in a report issued on Tuesday, July 30th. William Blair analyst B. Vazquez now anticipates that the company will earn $0.09 per share for the quarter, down from their previous estimate of $0.12. The consensus estimate for Neogen’s current full-year earnings is $0.56 per share. William Blair also issued estimates for Neogen’s Q2 2025 earnings at $0.12 EPS, Q4 2025 earnings at $0.18 EPS and FY2025 earnings at $0.54 EPS.

NEOG has been the subject of several other reports. Piper Sandler cut their price target on shares of Neogen from $19.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday, April 15th. StockNews.com upgraded shares of Neogen to a “sell” rating in a research report on Wednesday, July 10th.

Neogen Stock Performance

NASDAQ NEOG opened at $16.38 on Thursday. The company has a 50-day simple moving average of $16.01 and a two-hundred day simple moving average of $15.26. The company has a quick ratio of 2.66, a current ratio of 3.82 and a debt-to-equity ratio of 0.28. Neogen has a 12-month low of $11.46 and a 12-month high of $24.09. The firm has a market cap of $3.55 billion, a price-to-earnings ratio of 1,639.64 and a beta of 1.20.

Neogen (NASDAQ:NEOG) last released its earnings results on Tuesday, July 30th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The firm had revenue of $236.80 million during the quarter, compared to the consensus estimate of $225.83 million. Neogen had a negative net margin of 1.02% and a positive return on equity of 3.09%. The firm’s revenue was down 2.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.14 EPS.

Institutional Trading of Neogen

A number of institutional investors have recently modified their holdings of NEOG. Vanguard Group Inc. lifted its holdings in Neogen by 0.9% in the first quarter. Vanguard Group Inc. now owns 19,715,974 shares of the company’s stock worth $311,118,000 after buying an additional 169,237 shares during the period. Norges Bank purchased a new stake in Neogen in the fourth quarter worth about $365,794,000. Baillie Gifford & Co. lifted its holdings in Neogen by 42.3% in the first quarter. Baillie Gifford & Co. now owns 11,789,521 shares of the company’s stock worth $186,039,000 after buying an additional 3,502,807 shares during the period. Bamco Inc. NY increased its stake in shares of Neogen by 10.3% during the first quarter. Bamco Inc. NY now owns 7,304,967 shares of the company’s stock valued at $115,272,000 after purchasing an additional 680,668 shares in the last quarter. Finally, Conestoga Capital Advisors LLC increased its stake in shares of Neogen by 1.9% during the second quarter. Conestoga Capital Advisors LLC now owns 6,994,986 shares of the company’s stock valued at $109,332,000 after purchasing an additional 129,945 shares in the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.